UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders

Journal of neurochemistry, 2011-03, Vol.116 (5), p.828-832

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients

PloS one, 2015-03, Vol.10 (3), p.e0118312-e0118312

2015

Link zum Volltext

Verfügbarkeit prüfen

Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome

Journal of neurology, neurosurgery and psychiatry, 2020-12, Vol.91 (12), p.1339

2020

Link zum Volltext

Verfügbarkeit prüfen

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

Annals of neurology, 2004-10, Vol.56 (4), p.567-571

2004

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in experimental approaches to immune‐mediated neuropathy

Clinical & experimental neuroimmunology, 2018-05, Vol.9 (2), p.81-83

Kaida, Ken‐ichi

2018

Link zum Volltext

Verfügbarkeit prüfen

A new maneuver for repetitive nerve stimulation testing in the trapezius muscle

Muscle & nerve, 2013-05, Vol.47 (5), p.668-672

2013

Link zum Volltext

Verfügbarkeit prüfen

Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies

Journal of neurology, neurosurgery and psychiatry, 2017-06, Vol.88 (6), p.465

2017

Link zum Volltext

Verfügbarkeit prüfen

Guillain–Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review

Clinical & experimental neuroimmunology, 2018-05, Vol.9 (2), p.110-114

2018

Link zum Volltext

Verfügbarkeit prüfen

Renewal of the Editorial Board members: The dawn of a new era

Clinical & experimental neuroimmunology, 2018-05, Vol.9 (2), p.79-80

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Lancet neurology, 2018-06, Vol.17 (6), p.519-529

2018

Link zum Volltext

Verfügbarkeit prüfen

Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain–Barré syndromes

Journal of neuroimmunology, 2009-09, Vol.214 (1), p.125-127

2009

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against gangliosides and ganglioside complexes in Guillain–Barré syndrome: New aspects of research

Biochimica et biophysica acta, 2008-03, Vol.1780 (3), p.441-444

2008

Link zum Volltext

Verfügbarkeit prüfen

An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain–Barré syndrome with reversible conduction failure

Journal of neuroimmunology, 2013-01, Vol.254 (1), p.141-145

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

Multiple sclerosis, 2016-09, Vol.22 (10), p.1337-1348

2016

Link zum Volltext

Verfügbarkeit prüfen

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals

Clinical & experimental neuroimmunology, 2011-09, Vol.2 (3), p.59-67

2011

Link zum Volltext

Verfügbarkeit prüfen

Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy

Annals of neurology, 1999-03, Vol.45 (3), p.400-403

1999

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin

Journal of clinical neuroscience, 2013-11, Vol.20 (11), p.1618-1619

2013

Link zum Volltext

Verfügbarkeit prüfen

Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a

Glycobiology (Oxford), 2012-03, Vol.22 (3), p.352-360

2012

Link zum Volltext

Verfügbarkeit prüfen

Harmful effects of anti-GalNAc-GD1a antibodies and TNF-α on rat dorsal root ganglia

Journal of the peripheral nervous system, 2005-06, Vol.10 (2), p.190-201

2005

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline

Parkinsonism & related disorders, 2004-06, Vol.10 (4), p.235-242

2004

Link zum Volltext

Verfügbarkeit prüfen

Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2013-12, Vol.14 (7-8), p.608-614

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies

Advances in experimental medicine and biology, 2011, Vol.705, p.349

2011

Link zum Volltext

Verfügbarkeit prüfen

A case of Sjögren syndrome with subacute combined degeneration-like posterior column lesion on cervical MRI

Rinsho shinkeigaku = Clinical neurology, 2012, Vol.52 (7), p.491

2012

Link zum Volltext

Verfügbarkeit prüfen

A case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody

Rinsho Shinkeigaku, 2009, Vol.49(8), pp.488-492

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(32)
Science & Technology
(31)
Life Sciences & Biomedicine
(29)
Neurosciences & Neurology
(20)
Male
(19)
Middle Aged
(18)
Female
(17)
Clinical Neurology
(16)
Adult
(15)
Gangliosides - Immunology
(13)
Neurosciences
(13)
Aged
(11)
Guillain-Barre Syndrome - Immunology
(11)
Guillain-Barré Syndrome
(11)
Neurology
(10)
Guillain–barré Syndrome
(8)
G Ganglioside - Immunology
(7)
Adolescent
(6)
Antibodies
(6)
Biochemistry & Molecular Biology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders

Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients

Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

Recent advances in experimental approaches to immune‐mediated neuropathy

A new maneuver for repetitive nerve stimulation testing in the trapezius muscle

Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies

Guillain–Barré syndrome initially manifesting as motor weakness, urinary dysfunction and hyperreflexia: Case report and literature review

Renewal of the Editorial Board members: The dawn of a new era

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain–Barré syndromes

Antibodies against gangliosides and ganglioside complexes in Guillain–Barré syndrome: New aspects of research

An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain–Barré syndrome with reversible conduction failure

Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

Neuropathophysiological potential of Guillain-Barré syndrome anti-ganglioside-complex antibodies at mouse motor nerve terminals

Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy

Successful treatment of infliximab-associated immune-mediated sensory polyradiculopathy with intravenous immunoglobulin

Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a

Harmful effects of anti-GalNAc-GD1a antibodies and TNF-α on rat dorsal root ganglia

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Therapeutic factors causing hallucination in Parkinson's disease patients, especially those given selegiline

Recurrent K3E mutation in Cu/Zn superoxide dismutase gene associated with amyotrophic lateral sclerosis

Pathological roles of ganglioside mimicry in Guillain-Barré syndrome and related neuropathies

A case of Sjögren syndrome with subacute combined degeneration-like posterior column lesion on cervical MRI

A case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody

Suchergebnisse filtern